Buccal misoprostol for IUFD Research Group. Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: a double-blind randomized controlled trial
This study sought to assess whether buccal misoprostol is effective for treating intrauterine fetal death. The authors found that a 200 mcg dose, repeated at 6-hour intervals, was more effective than a 100 mcg dose in evacuating the uterus within 48 hours. Contraception. 2014 Mar;89(3):187-92.
Access abstract at http://www.ncbi.nlm.nih.gov/pubmed/24405797.